Buchhagen D L, Worsham M J, Dyke D L, Carey T E
Uniformed Services University of the Health Sciences, Department of Pathology, Bethesda, Maryland, USA.
Head Neck. 1996 Nov-Dec;18(6):529-37. doi: 10.1002/(SICI)1097-0347(199611/12)18:6<529::AID-HED7>3.0.CO;2-4.
Loss effecting the short arm of chromosome 3 occurs in nearly 60% of squamous cell carcinomas of the head and neck (SCCHN). Karyotype analysis indicated that these losses occur in two regions, 3p13-p14 and 3p21-p24. To test these findings, we examined tumor DNA from 38 SCCHN cell lines for heterozygosity and homozygosity at 6 polymorphic loci spanning this region.
The polymerase chain reaction (PCR) was used to amplify polymorphic restriction sites on 3p, the amplified products were digested with the appropriate restriction enzyme, electrophoresed on agarose gels, and assessed for the presence of one or both alleles. The 38 SCCHN cell lines were established from 31 patients and included 16 that had been karyotyped. In 6 cases two or three tumor cell lines established from separate tumors in the same patients were studied.
The cell lines exhibited a very low frequency of heterozygosity for the regions 3p12-3p21 (D3S3, D3S30 and D3S2) and distal 3p21-3p24 (D3F15S2 and THRB), when compared with that observed in the normal population. In contrast, D3S32, located within 3p21, was heterozygous in 38% of the tumors which is close to the frequency seen in the normal population (50%). In most cases the PCR results were consistent with the cytogenetic predictions. However, in 4 cell lines 3p loss was predicted from the karyotype, but heterozygosity for D3S32 was present.
These experiments support cytogenetic data that indicate two regions of 3p loss in SCCHN tumors. The 3p regions that show a high frequency of homozygosity may contain tumor suppressor genes involved in the development and/or progression of squamous cancer. The region surrounding D3S32 may contain an essential gene that is conserved in two copies even when much of 3p is lost.
3号染色体短臂缺失发生于近60%的头颈部鳞状细胞癌(SCCHN)中。核型分析表明这些缺失发生在两个区域,即3p13 - p14和3p21 - p24。为验证这些发现,我们检测了38个SCCHN细胞系的肿瘤DNA在跨越该区域的6个多态性位点处的杂合性和纯合性。
采用聚合酶链反应(PCR)扩增3p上的多态性限制性位点,扩增产物用适当的限制性酶消化,在琼脂糖凝胶上进行电泳,并评估一个或两个等位基因的存在情况。38个SCCHN细胞系来自31例患者,其中16个已进行核型分析。在6例中,研究了从同一患者不同肿瘤建立的两到三个肿瘤细胞系。
与正常人群相比,细胞系在3p12 - 3p21区域(D3S3、D3S30和D3S2)以及3p21远端 - 3p24区域(D3F15S2和THRB)表现出非常低的杂合频率。相比之下,位于3p21内的D3S32在38%的肿瘤中为杂合,这接近正常人群中观察到的频率(50%)。在大多数情况下,PCR结果与细胞遗传学预测一致。然而,在4个细胞系中,根据核型预测有3p缺失,但D3S32存在杂合性。
这些实验支持细胞遗传学数据,表明SCCHN肿瘤中3p有两个缺失区域。显示高频率纯合性的3p区域可能包含参与鳞状细胞癌发生和/或进展的肿瘤抑制基因。D3S32周围区域可能包含一个即使在3p大部分缺失时仍以两个拷贝形式保守的必需基因。